BIO-TECHNE DECLARES DIVIDEND
Bio-Techne declares $0.08/share quarterly dividend, payable Nov 23, 2026; record Nov 13 unless Merck KGaA deal closes first.
What this release says
Bio-Techne's Board declared a $0.08 per share dividend for the quarter ended September 30, 2026, payable November 23, 2026. The payment is conditional: it goes only to holders of record on November 13, 2026, and only if the pending transaction with Merck KGaA, Darmstadt, Germany has not closed by that date. Future dividends will be considered by the Board on a quarterly basis.
Key figures
- Dividend per share
- $0.08
- Payable date
- November 23, 2026
- Record date
- November 13, 2026
- Fiscal 2026 net sales
- over $1.2 billion
- Employees
- approximately 3,000
Positive for shareholders
- The Board has declared a quarterly cash dividend of $0.08 per share.
Negative for shareholders
- The dividend is paid only if the pending Merck KGaA transaction has not closed by November 13, 2026.
- Future dividends are not guaranteed and will be reviewed by the Board each quarter.
Written by Quantisnow AI from this release. Not financial advice.
Key terms
- Record date:
- The date a shareholder must be on the company's books to receive the declared dividend.
- Forward-looking statements:
- Statements about expected future events that carry risks and may turn out differently than predicted.
FAQ
How much dividend is Bio-Techne paying?
Bio-Techne is paying $0.08 per share for the quarter ended September 30, 2026.
What could stop Bio-Techne from paying this dividend?
The dividend is conditional: if the pending transaction with Merck KGaA, Darmstadt, Germany closes on or before November 13, 2026, the dividend will not be paid.
Historical context for TECH
Across the 26 sessions after earlier TECH headlines, the stock closed higher 14 times and lower 12 times, with a median move of 1.9% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | TECH | SPY |
|---|---|---|---|
| Oct 8, 2026 | Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development | -0.1% | -0.4% |
| Sep 23, 2026 | Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany | -0.0% | -0.7% |
| Sep 22, 2026 | Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration | +0.1% | -0.0% |
| Sep 1, 2026 | Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals | -0.2% | -0.7% |
| Aug 13, 2026 | Bio-Techne downgraded by Wells Fargo with a new price targetand 1 other headline that session | -0.1% | +0.7% |
| Aug 12, 2026 | Bio-Techne Releases Fourth Quarter Fiscal 2026 Resultsand 1 other headline that session | +0.1% | +0.3% |
Keep researching TECH
- TECH dividend historyDividends Bio-Techne Corp has declared, with ex-dates and payment dates.
- What is Dividend?A distribution of a company's profits or cash to shareholders, usually paid in cash on a regular schedule after being declared by the board.
- Dividend dates explainedTo receive a dividend you must own the stock before the ex-dividend date. Under T+1 settlement the ex-date now usually falls on the record date itself.
- Dividend trackerDividends declared across the market, with ex-dates and pay dates.
- TECH insider tradesEvery buy and sale reported by Bio-Techne Corp officers, directors and large holders.
- TECH earnings historyPast Bio-Techne Corp earnings releases, newest first.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
Follow TECH and get a push notification the moment its next story breaks.